Joe Kelley
Analyst · Sidoti & Company. Please proceed
Thank you, Jugal, and good morning to everyone joining us on the call today. During my comments I will cover a review of our third quarter 2017 financial highlights, profitability by segment, make some brief comments on the balance sheet, cash flow and modeling assumptions and finally cover the earnings outlook for the remainder of 2017. Following my remarks, the line will open for questions. We are pleased to report strong third quarter results, which exceeded the earnings guidance provided and represented the third consecutive quarter with year-over-year growth in both top-line value-added sales and operating profit. Third quarter 2017 value-added sales of $171.4 million increased 9% versus the third quarter of 2016. As a reminder, the Heraeus acquisition closed late in the first quarter of 2017 and accounted for $11.4 million of value added sales in the third quarter of 2017. If you recall we also recognized a large spot sale of raw material beryllium hydroxide in the third quarter of 2016. Compared to 2017 where under the new long term supply agreement we only recorded approximately one-third on the annual sales volumes of beryllium hydroxide in the third quarter. Excluding the impact of these two non-comparable factors, value-added sales grow 4% year-over-year in our base business. New product sales in the third quarter of 2017 totaled $30.7 million, an increase of 25% compared to the same period in the prior year. New product sales accounted for 18% of total value added sales in the third quarter of 2017, a new record level. We experienced strong demand in most key end markets, including our two largest end markets of consumer electronics and industrial components. Offset partially by a meaningful sales decline into the medical end market. Looking at gross profit margins, performance improvements in value based pricing and manufacturing operations largely offset the negative impact of lower medical end market sales. Gross profit margin as a percent of value-added sales was 32% in the third quarter of 2017 comparable to the third quarter of the prior year and an approximate 100 basis point increase over the second quarter of 2017. Sales, general and administrative expenses totaled $36.4 million, $2.2 million over the prior year third quarter of $34.2 million, due primarily to increase cost associated with the Heraeus' target business acquisition. SG&A expense as a percent of value added sales decreased to 21% in the third quarter of 2017 as compared to 22% in the prior year period. It is important to note that SG&A expense, excluding the impact of the acquired Heraeus' business is flat with the prior year as realized cost saving from cost reduction initiatives have offset CEO transition cost and variable expense directly related to value added sales growth and improved financial performance. Operating profit totaled $11.6 million in the third quarter of 2017. Adjusted operating profit, excluding special items was $13 million, an increase of almost 7% versus the prior year third quarter adjusted operating profit of $12.2 million. Performance improvements around commercial execution and sales growth combined with realized savings from cost reduction initiatives led to this increase. Net income in the third quarter of 2017 totaled $9.3 million versus $8.1 million of net income recorded in the prior year third quarter. Tax expense in the quarter was $1.7 million, reflective of an approximate 15% effective tax rate, comparable to the prior year and the year-to-date rate. However the effective tax rate on adjusted profits excluding special items is approximately 18%, in-line with guidance provided. Diluted earnings per share were $0.46 in the third quarter of 2017. Adjusted for special items, earnings totaled $0.50 per share in the third quarter of 2017, which compares to $0.46 per share of adjusted earnings in the third quarter of 2016, a 9% improvement in earnings. Now a review of our third quarter 2017 financial performance by business segment. Starting first with Advanced Materials. This segment delivered $60.4 million of value added sales in the third quarter of 2017, a more than 30% increase over $46 million of value added sales in the prior year third quarter. Excluding sales related to the acquisition, value-added sales growth was 7% year-over-year and represents the sixth consecutive with year-over-year organic growth for this segment. New product sales and strong end market demand in the segments largest end market of consumer electronics drove the increase in sales. Operating profit for the third quarter of 2017 totaled $9.8 million compared to $8.3 million in the third quarter of 2016. The 18% increase in adjusted operating profit was due to a combination of increased sales volume and improved performance in manufacturing and commercial execution. This business continues to performance and we are focused on maintaining this momentum as we continue to progress with the integration of the Heraeus’ acquisition which remains on schedule. Turning to our Performance Alloys and Composites business, third quarter 2017 value added sales were $90.6 million, up 4% compared to $87.2 million of value added sales in the third quarter of 2016. The year-over-year increase was net of a $3 million reduction in raw material beryllium hydroxide sales due to the large spot purchase in the third quarter of 2016. Excluding hydroxide sales, the base business value added sales increased 8% versus the prior year third quarter. The above market growth rate in value added sales was driven by success with new product introductions and commercial execution around value based pricing and improved product mix. Adjusted operating profit in the third quarter of 2017 was $7 million compared to $4.4 million in the same period last year and $6.2 million in the second quarter of 2017. The 59% year-over-year increase in profitability and 13% sequential improvement is reflective of successful implementation of the PAC recovery plan introduced last year. We are pleased with the continued progress we are making and returning to profitability of the PAC segment to historical levels. Adjusted operating profit margins as a percent of value added sales was 8% in the current quarter, the highest in over two years. We remain focused on identifying top line and cost reduction opportunities in this business, including yield and productivity improvements to drive further profit growth and margin expansion. Turning finally to our precision coatings business. The third quarter 2017 value added sales were $21.9 million compared to $25.8 million of value added sales in the third quarter of 2016. The year-over-year decrease in value added sales is due to the combination of a 44% decrease in value added sales of a large area coatings material into the blood glucose test strip market, offset by an 8% increase in the sales volume of precision optics. Here we continue to have success introducing new products for imaging and sensing applications. As mentioned on previous calls, a significant customer began a product transition to a next generation product line late in the fourth quarter of 2016, which has negatively impacted value added sales into the medical end market for the last four quarters. The customer’s product transition is complete and we are participating in the next generation product line. Adjusted operating profit was $2 million in the third quarter of 2017 or 9% of value added sales as compared to $3.4 million in the same period of the prior year. The decreased profit was due primarily to lower sales volume in the medical applications. We have taken actions in Asia and North America to reduce our headcount and related cost structures based on these lower sales volumes. We remain focused on identifying opportunities to improve the top line and grow the profits of this business segment. Moving to the balance sheet and cash flow, the company ended the third quarter of 2017 with a net cash position of $18.5 million, compared to a net debt position of $8.1 million at the end of the second quarter. Materion continues to have significant available liquidity to support capital allocation priorities we have mentioned previously, including organic growth opportunities, further inorganic strategic growth opportunities and to consistently return capital to shareholders. Cash flow provided from operating activities totaled $35.5 million in the quarter. We were able to grow operating cash flow year-over-year due to improved operating results and focus on reducing working capital investments. And finally key financial modeling assumptions. Cash flow from operations should run approximately $55 million to $60 million for the full year. Capital spending should run approximately $25 million and mine development investments should be less than $2 million. Annual depreciation should run approximately $43 million and an effective tax rate on adjusted earnings of 18% to 22% should be assumed. In terms of the earnings outlook for the remainder of 2017, we have delivered three consecutive quarters of value added sales and profitability growth on a year-over-year basis. The growth has been driven by strong performance, including record level new product sales, improved commercial execution, manufacturing efficiency and an improved cost structure. On our year-to-date performance and our expectation that these positive factors will continue for the balance of the year, we are narrowing the full year earnings guidance to $1.55 to $1.60 per share. This reflects the high end of the previously issued earnings guidance range of $1.45 to $1.60 per share. The midpoint of our updated guidance represents a forecasted improvement and profitability of approximately 20% compared to the full year 2016 results. Looking specifically at the fourth quarter, the midpoint of the guidance represents an approximate 30% year-over-year growth in adjusted earnings. This concludes our prepared remarks. We will now open the line for questions.